Supernus Pharmaceuticals
SUPN
$29.31
Share price
-3.14%
Change (1 day)
-21.63%
Change (1 year)
Categories
Operating Margin for Supernus Pharmaceuticals (SUPN)
Operating Margin as of April 2024 (TTM): 9.10%
According to Supernus Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 9.10%. At the end of 2022 the company had an Operating Margin of 9.10%.
Operating Margin history for Supernus Pharmaceuticals from 2011 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 9.10% | -27.87% |
| 2021 | 12.62% | -61.05% |
| 2020 | 32.41% | -13.7% |
| 2019 | 37.55% | 9.54% |
| 2018 | 34.28% | 2.98% |
| 2017 | 33.29% | 42.1% |
| 2016 | 23.43% | 125.99% |
| 2015 | 10.37% | -36.33% |
| 2014 | 16.28% | -102.12% |
| 2013 | -767.73% | -75.45% |
| 2012 | -3,127.30% | -36.38% |
| 2011 | -4,915.32% | -86.8% |
| 2010 | -37,239.62% | -341403.21% |
| 2009 | 10.91% | -102.9% |
| 2008 | -376.67% | -7.69% |
| 2007 | -408.04% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 151.43% | 🇺🇸 USA |
 Abbott Laboratories ABT | 15.60% | 71.43% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | 170.99% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | 111.43% | 🇺🇸 USA |
 Zogenix ZGNX | -259.55% | -2,952.22% | 🇺🇸 USA |
 United Therapeutics UTHR | 49.09% | 439.45% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.